Surgical Science Sweden

Surgical Science Sweden EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Surgical Science Sweden (SUS.ST) as of Nov 3, 2026 is 15.20. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 8.45 — a change of 79.96% (higher).

EV/FCF

15.20

YoY

79.96%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Surgical Science Sweden is 2025 15.20 . EV/FCF (Enterprise Value to Free Cash Flow) of Surgical Science Sweden was 2024 8.45 . It decreases by 79.96% higher compared to the previous year.

The Surgical Science Sweden EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-918.74 SEK
Jan 1, 2019
34.28 SEK
Jan 1, 2020
107.86 SEK
Jan 1, 2021
54.98 SEK
Jan 1, 2022
13.13 SEK
Jan 1, 2023
5.51 SEK
Jan 1, 2024
8.45 SEK
Jan 1, 2025
15.20 SEK
The Surgical Science Sweden EV/FCF history
YEAREV/FCFYoY
15.20+79.96%
8.45+53.40%
5.51-58.05%
13.13-76.13%
54.98-49.03%
107.86+214.69%
34.28-103.73%
-918.74+137.63%
-386.62-139.71%
973.71-147.16%
-2,064.86—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Surgical Science Sweden Stock analysis

What does Surgical Science Sweden do? Surgical Science Sweden AB is a Swedish company specializing in the development and manufacturing of medical simulators for training professionals in the medical industry. The company was founded in 1999 by a team of doctors, engineers, and scientists and is headquartered in Gothenburg. Since then, the company has constantly expanded and now has several branches around the world, including in the USA, Germany, and Hong Kong. Due to its innovative products and high-quality standards, the company is globally recognized and has received numerous awards. Surgical Science Sweden AB offers a wide range of simulators for various medical disciplines, including surgery, anesthesia, obstetrics, and pediatrics. They offer both hardware and software-based solutions that allow trainees to practice complex procedures and interventions in a safe environment. The company's business model is based on the belief that simulation is crucial for the training of medical professionals to ensure the highest quality and safety for patients. By simulating realistic situations, trainees can gain valuable experience before working in the real practice. Surgical Science Sweden AB has a range of products targeting various areas of medical education. One of their most well-known simulators is the LaparoSculptor, which was specifically developed for training in minimally invasive surgery. The simulator can perform various procedures such as gallbladder and hernia operations, offering both physical and virtual options. Another product is the ObstetricSim, a simulator for obstetric training. The simulator fully simulates the conditions of a normal birth, including the stages of labor and delivery. It also includes rare complications such as shoulder dystocia and umbilical cord prolapse. Surgical Science Sweden AB has also developed simulators focusing on the training of anesthesiologists. The simulator in this area is the ANTS (Anesthesia Simulator), which trains trainees in the proper use of anesthetics, patient observation, and managing emergencies during anesthesia issues. In addition to developing hardware and software solutions, the company also focuses on continuous improvement and development of its products. Surgical Science Sweden AB works closely with leading medical specialists to ensure that the simulator meets the latest requirements and best practices. The company is also willing to rent or sell the simulators and its expertise to medical institutions, providing a broader audience with the opportunity to benefit from the technology. In conclusion, Surgical Science Sweden AB makes a significant contribution to the training of medical professionals and thereby contributes to improving patient health worldwide with its innovative and high-quality simulators. By combining the latest technology, industry expertise, and a constant focus on customer needs, the company continuously strives for excellence and innovation. Surgical Science Sweden is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Surgical Science Sweden stock

EV/FCF (Enterprise Value to Free Cash Flow) of Surgical Science Sweden is 15.20 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Surgical Science Sweden changed from 8.45 to 15.20, representing a 79.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Surgical Science Sweden since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Surgical Science Sweden with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Surgical Science Sweden

All Key Metrics — Surgical Science Sweden